CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montano, X.
Right arrow Articles by Jimenez, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montano, X.
Right arrow Articles by Jimenez, A.

Cell Growth & Differentiation, Vol 6, Issue 5 597-605, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes

X Montano and A Jimenez
National Cancer Institute, Frederick Cancer Research Facility, Maryland 21701, USA.

Microinjection of the anti-ras antibody Mab Y13-259 modifies ras function and can induce temporary reversion of the transformed phenotype in mutant ras-transformed cells. Intracellular production of neutralizing antibodies represents an approach to investigate the regulation of gene function. The genes coding for the heavy and light chains of Mab Y13-259 were isolated from a cDNA library. NIH3T3 cells transfected with heavy and light chain expression vectors produced functional anti-ras antibody. The production of functional antibody did not require glycosylation. To ensure that the antibody entered the cytoplasm and not the secretory pathway, the hydrophobic leader sequences of both chains were removed and replaced with synthetic initiator sequences. The modified heavy chain gene was cloned under the control of the murine sarcoma virus long terminal repeat, and the light chain gene under the control of the mouse mammary tumor virus long terminal repeat, which allows the induction of light chain expression in the presence of dexamethasone. When both heavy and light chain genes were expressed in cells with activated ras (morphologically transformed) in the presence of dexamethasone, we observed phenotypic reversion to characteristics of nontransformed cells. These experiments show that intracellular expression of antibodies can also be used as an alternative to analyze biological functions of a given protein.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
V. Adler, M. R. Pincus, A. Polotskaya, X. Montano, F. K. Friedman, and Z.'e. Ronai
Activation of c-Jun-NH2-Kinase by UV Irradiation Is Dependent on p21ras
J. Biol. Chem., September 20, 1996; 271(38): 23304 - 23309.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.